Tech Company Financing Transactions

Topica Pharmaceuticals Funding Round

Prospect Venture Partners, Third Rock Ventures and Yasuda Enterprise Development joined a $27 million Series B venture round for Topica Pharmaceuticals. The round was recorded on 10/18/2011.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4300 El Camino Real 101
Los Altos, CA 94022
USA

Phone

(650) 209-3700

Website

www.topicapharma.com

Email Address

[email protected]

Overview

Topica Pharmaceuticals, Inc. is a privately held, clinical-stage specialty pharmaceutical company focused exclusively on developing the first highly effective, safe and convenient topical treatment for onychomycosis, or fungal infections of the toenail and nail bed.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Greg Vontz

        

Chief Financial Officer

Joseph Golemme

        

VP - General Counsel

Stephen Rosenfield

        

VP - Product Management

Katy Morton

        

VP - R & D

Norifumi Nakamura

        

Browse more venture capital transactions:

Prev: 10/17/2011: Eclipse Therapeutics venture capital transaction
Next: 10/18/2011: Sonexa Therapeutics venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary